“…Additionally, CS is a biocompatible and water-soluble polymer that could be considered as an alternative to poly(ethylene glycol) (PEG) chains when engineering long-circulating NPs. Hence, surface functionalization with CS may optimize the biodistribution and therapeutic effects of PLGA-based nanomedicines by: (i) providing hydrophilic and positively charged stealth coatings that could reduce or even inhibit protein corona formation, thus minimizing and delaying the opsonization process to evade phagocytosis [ 44 , 45 , 46 , 47 ], while favouring the uptake by targeted cells [ 48 , 49 ]; and, (ii) creating an additional barrier to drug diffusion during the early-time burst release of the biphasic drug release profile [ 50 , 51 ]. Incorporation of the CS shell onto a PLGA-based NP may take place by an attractive interaction between the negative PLGA matrix and the positive polysaccharide [ 52 ], and the idea has been applied to the production of magnetopolymer particles, i.e., (Fe 3 O 4 /PLGA)/CS [ 53 , 54 ] and ( γ -Fe 2 O 3 /PLGA)/CS [ 55 ] nanostructures.…”